These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiovascular Risk Factors in Childhood and Adulthood and Cardiovascular Disease in Middle Age. Kartiosuo N; Raitakari OT; Juonala M; Viikari JSA; Sinaiko AR; Venn AJ; Jacobs DR; Urbina EM; Woo JG; Steinberger J; Bazzano LA; Daniels SR; Magnussen CG; Rahimi K; Dwyer T JAMA Netw Open; 2024 Jun; 7(6):e2418148. PubMed ID: 38913374 [TBL] [Abstract][Full Text] [Related]
5. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010. Wong ND; Chuang J; Zhao Y; Rosenblit PD J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670 [TBL] [Abstract][Full Text] [Related]
6. Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events. Zhang Y; Pletcher MJ; Vittinghoff E; Clemons AM; Jacobs DR; Allen NB; Alonso A; Bellows BK; Oelsner EC; Zeki Al Hazzouri A; Kazi DS; de Ferranti SD; Moran AE JAMA Cardiol; 2021 Dec; 6(12):1406-1413. PubMed ID: 34550307 [TBL] [Abstract][Full Text] [Related]
7. Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study. Nuotio J; Oikonen M; Magnussen CG; Viikari JS; Hutri-Kähönen N; Jula A; Thomson R; Sabin MA; Daniels SR; Raitakari OT; Juonala M Atherosclerosis; 2015 Apr; 239(2):350-7. PubMed ID: 25682034 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease. Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866 [TBL] [Abstract][Full Text] [Related]
9. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study. Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651 [TBL] [Abstract][Full Text] [Related]
10. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study. Kaze AD; Santhanam P; Musani SK; Ahima R; Echouffo-Tcheugui JB J Am Heart Assoc; 2021 Apr; 10(7):e016947. PubMed ID: 33728932 [TBL] [Abstract][Full Text] [Related]
11. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study. Mora S; Buring JE; Ridker PM; Cui Y Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713 [TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Hedayatnia M; Asadi Z; Zare-Feyzabadi R; Yaghooti-Khorasani M; Ghazizadeh H; Ghaffarian-Zirak R; Nosrati-Tirkani A; Mohammadi-Bajgiran M; Rohban M; Sadabadi F; Rahimi HR; Ghalandari M; Ghaffari MS; Yousefi A; Pouresmaeili E; Besharatlou MR; Moohebati M; Ferns GA; Esmaily H; Ghayour-Mobarhan M Lipids Health Dis; 2020 Mar; 19(1):42. PubMed ID: 32178672 [TBL] [Abstract][Full Text] [Related]
14. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease. Pennell P; Leclercq B; Delahunty MI; Walters BA Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163 [TBL] [Abstract][Full Text] [Related]
15. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Quispe R; Elshazly MB; Zhao D; Toth PP; Puri R; Virani SS; Blumenthal RS; Martin SS; Jones SR; Michos ED Eur J Prev Cardiol; 2020 Oct; 27(15):1597-1605. PubMed ID: 31291776 [TBL] [Abstract][Full Text] [Related]
16. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study. Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203 [TBL] [Abstract][Full Text] [Related]
17. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis. Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study. Bao W; Srinivasan SR; Wattigney WA; Bao W; Berenson GS Arch Intern Med; 1996 Jun; 156(12):1315-20. PubMed ID: 8651840 [TBL] [Abstract][Full Text] [Related]
19. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study. Srinivasan SR; Frontini MG; Xu J; Berenson GS Pediatrics; 2006 Jul; 118(1):201-6. PubMed ID: 16818566 [TBL] [Abstract][Full Text] [Related]